COMMUNIQUÉS West-GlobeNewswire

Allena Pharmaceuticals Announces Appointment of Louis Brenner, M.D. as Chief Executive Officer and Confirms Key Milestones for 2019
04/01/2019
-- Alexey Margolin, Ph.D. to Transition to Chairman of the Board -- -- URIROX-2™ Initiated; URIROX-1™ Topline Data Expected in Second Half of 2019 -- -- Multiple Catalysts Expected Across Pipeline in 2019 -- NEWTON, [...]
BioTime Announces Management Changes Concurrent With Participation at 2019 J.P. Morgan Healthcare Conference and 2019 Biotech Showcase
04/01/2019
ALAMEDA, Calif., Jan. 04, 2019 (GLOBE NEWSWIRE) -- BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today announced the appointment of Brandi L. Roberts, M.B.A [...]
Shockwave Announces Appointment of Ray Larkin as Chairman of the Board
04/01/2019
SANTA CLARA, Calif., Jan. 04, 2019 (GLOBE NEWSWIRE) -- Shockwave Medical (“Shockwave”), a pioneer in the development and commercialization of intravascular lithotripsy to treat complex calcified cardiovascular disease, [...]
Canada House Announces Further Details of Vegreville Acquisition and Second Tranche of Funding from Alumina Partners
04/01/2019
TORONTO, Jan. 04, 2019 (GLOBE NEWSWIRE) -- Last month, Canada House Wellness Group Inc. (“Canada House” or the “Company”) was pleased to announce the acquisition through its wholly owned subsidiary Abba Medix Corp., of [...]
Result of General Meeting
04/01/2019
Summit Therapeutics plc (“Summit Therapeutics” or the “Company”) Result of General Meeting Oxford, UK, and Cambridge, MA, US, 4 January 2019 - Summit Therapeutics (AIM: SUMM, NASDAQ: SMMT), a leader in antibiotic [...]
Idera Pharmaceuticals to Present at the 37th Annual J.P. Morgan Healthcare Conference
04/01/2019
EXTON, Pa., Jan. 04, 2019 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) today announced that the company will present at the 37 th Annual J.P. Morgan Healthcare Conference on Wednesday, January 9, 2019 [...]
Chimerix to Present at the 37th Annual J.P. Morgan Healthcare Conference
04/01/2019
DURHAM, N.C., Jan. 04, 2019 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to address life-threatening viral infections, today announced that M. Michelle Berrey, M.D [...]
Biogen and Skyhawk Therapeutics Announce Agreement to Develop Novel Small Molecule RNA Splicing Modifiers for Neurological Disease Targets
04/01/2019
Biogen made a one-time upfront $74 million payment to Skyhawk for research services and an exclusive license to therapeutic candidates for multiple sclerosis, spinal muscular atrophy and other neurological diseases to [...]
Biogen and C4 Therapeutics Enter into Strategic Collaboration to Discover and Develop Potential New Treatments for Neurological Conditions
04/01/2019
C4T’s targeted protein degradation platform provides a novel approach to neuroscience drug discovery and development, complementing Biogen’s broader research and development efforts across multiple modalities CAMBRIDGE [...]
Eckert & Ziegler BEBIG: Meeting Minutes Extraordinary General Meeting
04/01/2019
Seneffe, January 4, 2019. The Minutes and all relevant documents regarding the Extraordinary General Assembly 2018 can be downloaded on the website: http://www.bebig.com/home/investors/shareholder_information/ About [...]
Eckert & Ziegler BEBIG: Procès verbal de l'assemblée générale extraordinaire des actionnaires
04/01/2019
Seneffe, le 4 janvier 2019. Le procès verbal ainsi que tous les documents relatifs à l'assemblé générale extraordinaire 2018 peuvent être téléchargés sur le site internet: http://www.bebig.com/home/investors/ [...]
Zealand Pharma completes equity investment in strategic partner Beta Bionics
04/01/2019
Press release – No. 1 / 2019 Zealand Pharma completes equity investment in strategic partner Beta Bionics Zealand Pharma invests USD 3.5 million in the final close of strategic partner Beta Bionics’ series B financing [...]
Orion Corporation and Fifth Corner Inc join forces to research solutions for improving the quality of life of prostate cancer patients
04/01/2019
Orion Corporation Press release 4 January 2019 at 9.00 a.m. Orion Corporation and Fifth Corner Inc join forces to research solutions for improving the quality of life of prostate cancer patients Orion Corporation, a [...]
ASLAN Pharmaceuticals Announces IND Submission for ASLAN003 to U.S. FDA and Conclusion of 30-Day Review Period
04/01/2019
- ASLAN003 is an orally active, potent inhibitor of DHODH that has the potential to be first-in-class in AML - Positive interim Phase 2a data for ASLAN003 in AML was presented at the 2018 ASH Annual Meeting SINGAPORE, [...]
VYZULTA Approved in Canada by Nicox's Partner
04/01/2019
Press Release VYZULTA Approved in Canada by Nicox's Partner ............................................... January 4, 2019 - release at 7:30 am CET Sophia Antipolis, France Nicox SA (Euronext Paris: FR0013018124, COX [...]
VYZULTA approuvé au Canada par le partenaire licencié de Nicox
04/01/2019
Communiqué de presse VYZULTA TM approuvé au Canada par le partenaire licencié de Nicox ................................................. 4 janvier 2019 - diffusion à 7h30 Sophia Antipolis, France Nicox SA (Euronext [...]
Basilea presenting at the 37th Annual J. P. Morgan Healthcare Conference - delivering on its strategy
04/01/2019
Basel, Switzerland, January 04, 2019 - Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that David Veitch, Chief Executive Officer of Basilea, will present at the 37 th Annual J. P. Morgan Healthcare Conference on [...]
Kiadis Pharma expands presence in the United States
04/01/2019
Kiadis Pharma expands presence in the United States Scott Holmes commences position as chief financial officer Amy Sullivan appointed senior vice president, corporate affairs Both are based in Boston, Massachusetts [...]
WishBone Medical’s response to OrthoPediatrics press release
04/01/2019
WARSAW, Ind., Jan. 03, 2019 (GLOBE NEWSWIRE) -- The following is a statement by WishBone Medical: “Both the motion and OrthoPediatrics’ case as a whole are without merit and OP knows it. OP is merely trying to use this [...]

Pages